DK1511741T3 - Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika - Google Patents

Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika

Info

Publication number
DK1511741T3
DK1511741T3 DK03747269.3T DK03747269T DK1511741T3 DK 1511741 T3 DK1511741 T3 DK 1511741T3 DK 03747269 T DK03747269 T DK 03747269T DK 1511741 T3 DK1511741 T3 DK 1511741T3
Authority
DK
Denmark
Prior art keywords
decahydroisoquinoline
analgesics
carboxylic acid
ester derivatives
derivatives
Prior art date
Application number
DK03747269.3T
Other languages
English (en)
Inventor
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1511741T3 publication Critical patent/DK1511741T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK03747269.3T 2002-04-26 2003-04-14 Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika DK1511741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37612002P 2002-04-26 2002-04-26
PCT/US2003/010466 WO2003091243A1 (en) 2002-04-26 2003-04-14 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics

Publications (1)

Publication Number Publication Date
DK1511741T3 true DK1511741T3 (da) 2013-01-21

Family

ID=29270765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03747269.3T DK1511741T3 (da) 2002-04-26 2003-04-14 Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika

Country Status (18)

Country Link
US (1) US7247644B2 (da)
EP (1) EP1511741B1 (da)
JP (2) JP2005529892A (da)
KR (1) KR100757787B1 (da)
CN (1) CN100436446C (da)
AU (1) AU2003226277B2 (da)
BR (1) BR0308911A (da)
CA (1) CA2480026C (da)
DK (1) DK1511741T3 (da)
EA (1) EA009526B1 (da)
ES (1) ES2398225T3 (da)
IL (1) IL164773A (da)
MX (1) MXPA04009857A (da)
NZ (1) NZ535245A (da)
PT (1) PT1511741E (da)
SI (1) SI1511741T1 (da)
WO (1) WO2003091243A1 (da)
ZA (1) ZA200409552B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ535245A (en) * 2002-04-26 2007-11-30 Lilly Co Eli Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgesics
WO2008088820A2 (en) 2007-01-16 2008-07-24 The Johns Hopkins University Glutamate receptor antagonists and methods of use
EP4175635A4 (en) * 2020-07-02 2024-06-26 Sea Pharmaceuticals LLC PHARMACEUTICAL COMPOSITIONS OF 6-(2-(2H-TETRAZOL-5-YL)ETHYL)-6-FLUORODECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AND ESTER DERIVATIVES THEREOF
IL309097A (en) * 2021-06-09 2024-02-01 Proniras Corp Methods for treating seizures caused by a nerve agent
WO2023130008A2 (en) * 2022-01-01 2023-07-06 Sea Pharmaceuticals Llc Pharmaceutical compositions of 6-(2-(2h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid and derivatives thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5284957A (en) 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5356902A (en) 1992-11-06 1994-10-18 Eli Lilly And Company Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists
US5446051A (en) 1994-05-31 1995-08-29 Eli Lilly And Company Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
US5767117A (en) 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
IL132086A0 (en) 1997-04-07 2001-03-19 Lilly Co Eli Pharmacological agents
EP1208087B1 (en) * 1999-07-06 2003-05-14 Eli Lilly And Company Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
JP4619595B2 (ja) 1999-07-06 2011-01-26 イーライ リリー アンド カンパニー 偏頭痛の処置のための選択的なｉＧｌｕＲ５受容体拮抗薬
AU2574801A (en) 1999-12-22 2001-07-03 Eli Lilly And Company Selective iGLUR5 receptor antagonists
AU2002228736A1 (en) 2001-01-05 2002-07-16 Eli Lilly And Company Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
ATE397931T1 (de) 2001-01-05 2008-07-15 Lilly Co Eli Exzitatorische aminosäure-rezeptor-antagonisten
AU2001298029A1 (en) 2001-01-05 2003-04-01 Eli Lilly And Company Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
AU2002227020A1 (en) 2001-01-05 2002-07-16 Eli Lilly And Company Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
AU2003219955A1 (en) 2002-03-22 2003-10-13 Eli Lilly And Company Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
NZ535245A (en) * 2002-04-26 2007-11-30 Lilly Co Eli Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgesics

Also Published As

Publication number Publication date
IL164773A0 (en) 2005-12-18
EP1511741A1 (en) 2005-03-09
SI1511741T1 (sl) 2013-02-28
MXPA04009857A (es) 2004-12-07
CN1649862A (zh) 2005-08-03
KR100757787B1 (ko) 2007-09-11
AU2003226277A1 (en) 2003-11-10
ZA200409552B (en) 2006-02-22
KR20040102171A (ko) 2004-12-03
NZ535245A (en) 2007-11-30
EA009526B1 (ru) 2008-02-28
PT1511741E (pt) 2013-02-05
US7247644B2 (en) 2007-07-24
IL164773A (en) 2011-08-31
WO2003091243A8 (en) 2005-03-31
CA2480026A1 (en) 2003-11-06
CN100436446C (zh) 2008-11-26
WO2003091243A1 (en) 2003-11-06
ES2398225T3 (es) 2013-03-14
JP2005529892A (ja) 2005-10-06
CA2480026C (en) 2011-06-07
EA200401432A1 (ru) 2005-04-28
EP1511741B1 (en) 2012-12-26
BR0308911A (pt) 2005-01-04
JP2010235623A (ja) 2010-10-21
AU2003226277B2 (en) 2009-03-26
US20050256155A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
DK1488790T3 (da) Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat
NO2014011I2 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
NO20052921D0 (no) Fenylsubstituerte piperidinforbindelser for anvendelse som PPAR aktivatorer
FI20002767A (fi) Jodoniumsuolat latentteina happodonoreina
DK1523493T3 (da) Nye tubulysinanaloge
IS7818A (is) Tafin losun á amfetamínsöltum
NO20031784L (no) Heteroarylalkylpiperazinderivater som fettsyre- oksydasjonsinhibitorer
NO20030867D0 (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
DK1660431T3 (da) Phenoxyeddikesyrederivater
NO20044998L (no) Tioksantinderivater som myeloperoksidaseinhibitorer
EE200400023A (et) Uued sulfoonhappe derivaadid
HK1073102A1 (en) Sulphonic acid salts of mandelic acid derivatives
NO331228B1 (no) Anvendelse av en sammensetning som omfatter et ketotifensalt
DE60307258D1 (de) Tolterodin-salze
DK1414824T3 (da) Nye antikonvulsive derivatsalte
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK1511741T3 (da) Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika
DE10392970D2 (de) Lagerung einer Welle
IS7195A (is) Ný vatnsfrí kristallaform af gabapentíni
DK1224164T3 (da) Hydroxaminsyrederivat som inhibitor for produktion af oplöselig human CD23
DK1497290T3 (da) Fremgangsmåde til fremstilling af syresalte af gemifloxacin
DK1253917T3 (da) Anvendelse af substituerede 4-amino-1-phenylbutan-2-ol-forbindelser som lægemiddel
DE60317481D1 (de) Produktion einer ugppase
NO20043743L (no) Karboksylsyreforbindelser for anvendelse som overflateaktive midler